Sarah Cannon Research Institute
|Industry:||Hospital & Health Care|
Sarah Cannon Research Institute (SCRI) is a strategic research organization focusing on advancing therapies for patients and accelerating drug development. With corporate headquarters in Nashville, Tennessee, it conducts community-based clinical trials in oncology, cardiology, gastroenterology and other therapeutic areas through its affiliation with a network of hundreds of physicians. The current CEO is Dee Anna Smith.